GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:
Castellum AB (STO:CAST):
Gunnar Östenson resigns at his own request as MD of Fastighets AB Briggen as of January 27, 2014. Gunnar was appointed as MD of Briggen in September 2006 and has since then meritoriously developed the company in project development as well as customer service. During Gunnars’s years at Briggen the company has also been established in Denmark.
“I regret that Gunnar choose to leave Briggen. During Gunnar’s seven years as MD for Briggen the company has developed strongly and many positive changes have been implemented. Gunnar has been valuable in the development of Briggen as well as the Castellum Group”, says Castellum’s CEO Henrik Saxborn. “I wish him all the best in future missions”, adds Saxborn.
“I want to thank Briggen’s customers and other business partners for this time and especially my colleagues for a fantastic commitment and drive during the past years”, says Gunnar Östenson.
Until a new MD has been appointed for Fastigets AB Briggen Tage Christoffersson, head of Business Development at Castellum AB, will take over as acting MD of Fastighets AB Briggen. The process of recruiting a new MD of Fastighets AB Briggen starts immediately.
Castellum AB (publ) discloses the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act.
Castellum is one of the major listed real estate companies in Sweden. The fair value of the real estate portfolio amounts to approx. SEK 38 billion, and comprises premises for office, retail, warehouse and industrial purposes with a total lettable area of approx 3.6 million sq.m. The real estate portfolio is owned and managed by six wholly owned subsidiaries with strong local roots in five growth regions: Greater Gothenburg, the Öresund Region, Greater Stockholm, Mälardalen and Eastern Götaland.
Castellum is listed on NASDAQ OMX Stockholm AB Large Cap.
Castellum AB (publ), Box 2269, SE-403 14 Göteborg | Org nr/Corp Id no SE 556075-5550 | Phone +46 31 60 74 00 Fax +46 31 13 17
This information was brought to you by Cision http://news.cision.com